DJ-1 Is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation

PLoS Biology

Volumn 2, Issue 11, 2004, Pages

  Shendelman, Shoshana ^a   Jonason, Alan ^a   Martinat, Cecile ^a   Leete, Thomas ^a   Abeliovich, Asa ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; CHAPERONE; DJ 1 PROTEIN; PROTEASOME; PROTEIN; UNCLASSIFIED DRUG; ANTIOXIDANT; CYSTEINE; DOPAMINE; ONCOPROTEIN; OXYGEN; PARK7 PROTEIN, HUMAN; SIGNAL PEPTIDE; SYNUCLEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE MUTATION; IN VIVO STUDY; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN FUNCTION; CELL DIFFERENTIATION; CHEMISTRY; DIMERIZATION; GENE VECTOR; HELA CELL; HOMOZYGOTE; HUMAN; METABOLISM; MUTATION; NERVE CELL; PARKINSON DISEASE; PHYSIOLOGY; SPECTROPHOTOMETRY; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; ANTIOXIDANTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYSTEINE; CYTOPLASM; DIMERIZATION; DOPAMINE; GENETIC VECTORS; HELA CELLS; HOMOZYGOTE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR CHAPERONES; MUTATION; NEURONS; ONCOGENE PROTEINS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN; PARKINSON DISEASE; SPECTROPHOTOMETRY; SYNUCLEINS;

EID: 13944267769     PISSN: 15449173     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pbio.0020362     Document Type: Article

References (48)

1. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, et al. (2000) Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25: 239-252.
2. Beal MF (2002) Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32: 797-803.
3. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259.
4. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, et al. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101: (24) 9103-9108.
5. Chelikani P, Donald LJ, Duckworth HW, Loewen PC (2003) Hydroperoxidase II of Escherichia coli exhibits enhanced resistance to proteolytic cleavage compared to other catalases. Biochemistry 42: 5729-5735.
6. Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, et al. (2000a) Accelerated oligomerization by Parkinson's disease linked α-synuclein mutants. Ann N Y Acad Sci 920: 42-45.
7. Conway KA, Harper JD, Lansbury PT (2000b) Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39: 2552-2563.
8. Dauer W, Przedborski S (2003) Parkinson's disease: Mechanisms and models. Neuron 39: 889-909.
9. de Nobel H, Lawrie L, Brul S, Klis F, Davis M, et al. (2001) Parallel and comparative analysis of the proteome and transcriptome of sorbic acid-stressed Saccharomyces cerevisiae. Yeast 18: 1413-1428.
10. Du X, Choi IG, Kim R, Wang W, Jancarik J, et al. (2000) Crystal structure of an intracellular protease from Pyrococcus horikoshii at 2-Å resolution. Proc Natl Acad Sci U S A 97: 14079-14084.
11. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, et al. (2000) Oxidative damage linked to neurodegeneration by selective α- synuclein nitration in synucleinopathy lesions. Science 290: 985-989.
12. Goldberg MS, Lansbury PT (2000) Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? Nat Cell Biol 2: E115-119.
13. Gosavi N, Lee HJ, Lee JS, Patel S, Lee SJ (2002) Golgi fragmentation occurs in the cells with prefibrillar α-synuclein aggregates and precedes the formation of fibrillar inclusion. J Biol Chem 277: 48984-48992.
14. Gusev NB, Bogatcheva NV, Marston SB (2002) Structure and properties of small heat shock proteins (sHsp) and their interaction with cytoskeleton proteins. Biochemistry (Mosc) 67: 511-519.
15. Halio SB, Blumentals II, Short SA, Merrill BM, Kelly RM (1996) Sequence, expression in Escherichia coli and analysis of the gene encoding a novel intracellular protease (PfpI) from the hyperthermophilic archaeon Pyrococcus furiosus. J Bacteriol 178: 2605-2612.
16. Hattori N, Shimura H, Kubo S, Kitada T, Wang M, et al. (2000) Autosomal recessive juvenile parkinsonism: A key to understanding nigral degeneration in sporadic Parkinson's disease. Neuropathology 20: (Suppl) S85-90.
17. Honbou K, Suzuki NN, Horiuchi M, Niki T, Taira T, et al. (2003a) The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. J Biol Chem 278: 31380-31384.
18. Honbou K, Suzuki NN, Horiuchi M, Taira T, Niki T, et al. (2003b) Crystallization and preliminary crystallographic analysis of DJ-1, a protein associated with male fertility and parkinsonism. Acta Crystallogr D Biol Crystallogr 59: 1502-1503.
19. Horvath MM, Grishin NV (2001) The C-terminal domain of HPII catalase is a member of the type I glutamine amidotransferase superfamily. Proteins 42: 230-236.
20. Huai Q, Sun Y, Wang H, Chin LS, Li L, et al. (2003) Crystal structure of DJ-1/RS and implication on familial Parkinson's disease. FEBS Lett 549: 171-175.
21. Jakob U, Muse W, Eser M, Bardwell JC (1999) Chaperone activity with a redox switch. Cell 96: 341-352.
22. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53: (Suppl 3) 26-38.
23. Lee HJ, Lee SJ (2002) Characterization of cytoplasmic α-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol Chem 277: 48976-48983.
24. Lee HJ, Shin SY, Choi C, Lee YH, Lee SJ (2002) Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors. J Biol Chem 277: 5411-5417.
25. Lee SJ, Kim SJ, Kim IK, Ko J, Jeong CS, et al. (2003) Crystal structures of human DJ-1 and Escherichia coli Hsp31 that share an evolutionarily conserved domain. J Biol Chem 278: 44552-44559.
26. Malki A, Kern R, Abdallah J, Richarme G (2003) Characterization of the Escherichia coli YedU protein as a molecular chaperone. Biochem Biophys Res Commun 301: 430-436.
27. Martinat C, Shendelman SB, Jonason A, Leete T, Beal MF, et al. (2004) Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: An ES-derived cell model of primary parkinsonism. PLoS Biol 2: (11) e327.
28. McCormack AL, Thiruchelvam M, Manning-Bog AB, Thiffault C, Langston JW, et al. (2002) Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat. Neurobiol Dis 10: 119-127.
29. Miller DW, Ahmad R, Hague S, Baptista MJ, Canet-Aviles R, et al. (2003) L166P mutant DJ-1, causative for recessive Parkinson's disease, is degraded through the ubiquitin-proteasome system. J Biol Chem 278: 36588-36595.
30. Mitsumoto A, Nakagawa Y (2001) DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic Res 35: 885-893.
31. Mitsumoto A, Nakagawa Y, Takeuchi A, Okawa K, Iwamatsu A, et al. (2001) Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic Res 35: 301-310.
32. Nagakubo D, Taira T, Kitaura H, Ikeda M, Tamai K, et al. (1997) DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun 231: 509-513.
33. Olanow CW, Tatton WG (1999) Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123-144.
34. Olzmann JA, Brown K, Wilkinson KD, Rees HD, Huai Q, et al. (2003) Familial Parkinson's disease-associated L166P mutation disrupts DJ-1 protein folding and function. J Biol Chem 279: 8506-8515.
35. Perez-Olle R, Leung CL, Liem RK (2002) Effects of Charcot-Marie- Toothlinked mutations of the neurofilament light subunit on intermediate filament formation. J Cell Sci 115: 4937-4946.
36. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
37. Rideout HJ, Larsen KE, Sulzer D, Stefanis L (2001) Proteasomal inhibition leads to formation of ubiquitin/α-synuclein-immunoreactive inclusions in PC12 cells. J Neurochem 78: 899-908.
38. Sastry MS, Korotkov K, Brodsky Y, Baneyx F (2002) Hsp31, the Escherichia coli yedU gene product, is a molecular chaperone whose activity is inhibited by ATP at high temperatures. J Biol Chem 277: 46026-46034.
39. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, et al. (1997) α-synuclein in Lewy bodies. Nature 388: 839-840.
40. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, et al. (1998) Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 251: 205-208.
41. Sreerama N, Woody R. W (2003) Structural composition of β(I)- and β(II)-proteins. Protein Sci 12: 384-388.
42. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, et al. (2003) Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37: 735-749.
43. Taira T, Saito Y, Niki T, Iguchi-Ariga SM, Takahashi K, et al. (2004) DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep 5: 213-218.
44. Tao X, Tong L (2003) Crystal structure of human DJ-1, a protein associated with early onset Parkinson's disease. J Biol Chem 278: 31372-31379.
45. Trojanowski JQ, Lee VM (1998) Aggregation of neurofilament and α-synuclein proteins in Lewy bodies: Implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch Neurol 55: 151-152.
46. Volles MJ, Lee SJ, Rochet JC, Shtilerman MD, Ding TT, et al. (2001) Vesicle permeabilization by protofibrillar α-synuclein: Implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40: 7812-7819.
47. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT (1996) NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35: 13709-13715.
48. Wilson MA, Collins JL, Hod Y, Ringe D, Petsko GA (2003) The 1.1-Å resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. Proc Natl Acad Sci U S A 100: 9256-9261.